Drug
Treprostinil hexadecyl ester clinical trials
Also written INS1009 and Treprostinil Palmitil.
- studies test it
- 12
- open now
- 5
- in phase 3
- 6
- first study started
- 2020
Keep track of what changes. Save the treprostinil hexadecyl ester studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Development codes
- INS1009
- 12
Other names
Studies by the year they started
12 studies that test it; most in 2026 (5)
| Year | Studies |
|---|---|
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2025 | 1 |
| 2026 | 5 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 5
- Phase 3
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 12 · Other 0
Studies
Open first, then newest update. How each study uses treprostinil hexadecyl ester is read from its arms, and is right about nine times in ten.
Testing it · 12
- Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)RecruitingPhase 3Insmed IncorporatedNCT07179380Written as Treprostinil Palmitil Inhalation Powder
- A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)RecruitingPhase 3Insmed IncorporatedNCT07481981Written as Treprostinil Palmitil Inhalation Powder
- A Study to Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Normal Hepatic Function and Participants With Hepatic ImpairmentRecruitingPhase 1Insmed IncorporatedNCT07643155Written as Treprostinil Palmitil Inhalation Powder
- A Study to Assess the Efficacy and Safety of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Progressive Pulmonary Fibrosis (PPF)Not yet recruitingPhase 3Insmed IncorporatedNCT07805785Written as Treprostinil Palmitil Inhalation Powder
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)RecruitingPhase 3Insmed IncorporatedNCT07234032Written as Treprostinil Palmitil Inhalation Powder
- An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH)Active, not recruitingPhase 2/3Insmed IncorporatedNCT05649748Written as Treprostinil Palmitil
- An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)CompletedPhase 2/3Insmed IncorporatedNCT05649722Written as Treprostinil Palmitil Inhalation Powder
- A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial HypertensionCompletedPhase 2Insmed IncorporatedNCT05147805Written as Treprostinil Palmitil
- A Study to Assess the Relative Bioavailability After a Single Inhalation Administration of Treprostinil Palmitil Inhalation Powder (TPIP) Formulation 2 (F2) to TPIP Formulation 3 (F3) in Healthy ParticipantsCompletedPhase 1Insmed IncorporatedNCT07102316Written as TPIP F2
- A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung DiseaseCompletedPhase 2Insmed IncorporatedNCT05176951Written as Treprostinil Palmitil
- A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy ParticipantsCompletedPhase 1Insmed IncorporatedNCT06091579Written as Treprostinil Palmitil Inhalation Powder
- A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH)TerminatedPhase 2Insmed IncorporatedNCT04791514Written as Treprostinil Palmitil
Codes
What other systems call treprostinil hexadecyl ester · ClinicalTrials.gg INT015661
- UNII (FDA) 8GJK87S89FTREPROSTINIL PALMITILConfirmed FDA, Wikidata
- Wikidata Q27270416treprostinil hexadecyl esterConfirmed FDA, Wikidata
- DrugBank DB18792One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8GJK87S89F | TREPROSTINIL PALMITIL | Confirmed FDA, Wikidata |
| Wikidata | Q27270416 | treprostinil hexadecyl ester | Confirmed FDA, Wikidata |
| DrugBank | DB18792 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.